Dimensional Fund Advisors’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABOS
PWMAG
CA
Dimensional Fund Advisors's ABOS Position: Q3 2026 in Review
Dimensional Fund Advisors increased its Acumen Pharmaceuticals (ABOS) stake by 11% in Q3 2026, buying an estimated $83.9K and bringing the position to 323,999 shares worth $719K. The position accounts for ﹤0.01% of the portfolio, ranked #2886.
Dimensional Fund Advisors first reported a position in ABOS in Q1 2023 and has held it in 15 quarters since. The position peaked at $779K in Q2 2026. 28 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.
- Dimensional Fund Advisors held 323,999 shares of Acumen Pharmaceuticals worth $719K as of Q3 2026.
- Dimensional Fund Advisors bought 32,440 Acumen Pharmaceuticals shares in Q3 2026, an estimated $83.9K.
- Acumen Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2886 holding.
- Dimensional Fund Advisors first reported a position in Acumen Pharmaceuticals in Q1 2023 and has held it in 15 quarters since.
- Dimensional Fund Advisors's Acumen Pharmaceuticals position peaked at $779K in Q2 2026.
- 28 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.